Hu et al. have confirmed elevated serum S100β levels in SAE individuals vs non-encephalopathy septic individuals [45], and others have shown its value in evaluating brain injury severity [46] and poor prognoses [28]. This evidence concerns the gene S100B and Encephalopathy.